Keywords: heptovir, approved, canada, glaxo, wellcome, biochem, pharma

Heptovir Approved In Canada

Article | 02 December 1998

Print This

Glaxo Wellcome and BioChem Pharma's Heptovir (lamivudine) has beenapproved by the Therapeutic Products Program of Health Canada. The drug is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in